Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Prostatic Neoplasms 7 Brain Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 4 Sarcoma 4 Carcinoma, Non-Small-Cell Lung 4 Solid Tumor, Adult 3 Rhabdomyosarcoma 3 Neoplasms 3 Meningioma 3 Glioma 3 Pituitary Neoplasms 2 Osteosarcoma 2 Nerve Sheath Neoplasms 2 Glioblastoma 2 Esophageal Neoplasms 2 Craniopharyngioma 2 Chordoma 2 Chondrosarcoma 2 Breast Neoplasms 2 Bone Neoplasms 2 Wilms Tumor 1 Vascular Neoplasms 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Solitary Fibrous Tumors 1 Solid Tumor 1 Smooth Muscle Tumor 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrent Head and Neck Carcinoma 1

Interventions

Cisplatin 15 Pemetrexed 12 pembrolizumab 9 Carboplatin 8 Nivolumab 7 Cyclophosphamide 6 Platinum 5 Ipilimumab 5 1,2-diaminocyclohexaneplatinum II citrate 5 fludarabine 3 Radiotherapy, Intensity-Modulated 3 Interleukin-2 3 Gemcitabine 3 tremelimumab 2 durvalumab 2 atezolizumab 2 aldesleukin 2 Radiotherapy 2 Radiation 2 Photochemotherapy 2 Pharmaceutical Preparations 2 Methotrexate 2 Drug Therapy 2 Chemotherapy, Adjuvant 2 Cerebral Decortication 2 nintedanib 1 methoxyamine 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 cediranib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Proton Therapy × 1 year × Clear all

NCT05655078 2026-03-30

HIT-Meso

University College, London

Phase NA Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡